Ketorol

Ketorolac Trometamol, the active ingredient in Ketorol, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular and intravenous use. It is employed for short‑term management of moderate to severe acute pain, including post‑operative pain, in adult patients.

GNH USA supplies Ketorol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export. Clients benefit from reliable logistics and responsive technical support across multiple continents.

Ketorolac Trometamol is an NSAID that provides analgesia by reducing prostaglandin‑mediated inflammation.

- Moderate to severe acute pain: provides rapid, short‑term analgesia for adult patients after injury, medical procedures, or other painful events. - Post‑operative pain: effectively reduces pain intensity and opioid requirement following surgical interventions such as orthopedic, abdominal, or dental surgery. - Dental pain after extraction or oral surgery: controls postoperative discomfort and facilitates recovery in dental patients. - Acute musculoskeletal pain: offers temporary relief for sprains, strains, or soft‑tissue injuries where short‑duration NSAID therapy is appropriate.

Ketorolac may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Headache - Dizziness - Injection site pain

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Acute renal impairment - Severe allergic reactions such as anaphylaxis - Cardiovascular events including myocardial infarction or stroke

When using Ketorolac, clinicians should observe several safety considerations to minimise risk.

- Renal function: assess baseline renal status and avoid use in severe renal impairment. - Bleeding risk: avoid in patients with active peptic ulcer disease or concurrent anticoagulant therapy. - Cardiovascular disease: use cautiously in individuals with coronary artery disease or hypertension. - Pregnancy: contraindicated in the third trimester and should be avoided during pregnancy unless clearly needed. - Elderly patients: monitor closely for renal and gastrointestinal adverse effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ketorolac can interact with several medicines, altering its safety or efficacy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, heparin): increased risk of serious bleeding. - Concomitant NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion and function. - Diuretics: potential for renal impairment when combined. - Lithium: ketorolac may raise serum lithium concentrations.